CONTACT-02 Trial Results: Cabozantinib and Atezolizumab in Metastatic Prostate Cancer The combination of cabozantinib (Cabometyx) and atezolizumab (Tecentriq) reduced the risk of disease progression or death by approximately 35% in …
medicament
-
-
Health
Revolutionizing Nutrition: How Wearables, AI, and Personalization Are Changing Health Tracking in Singapore
How AI and Wearables Are Reshaping Personalized Nutrition in Singapore Singapore-based Nutricode, a company specializing in AI-driven health solutions, has announced a new phase in personalized nutrition that leverages wearable …
-
Cancer and cardiovascular diseases remain the leading causes of death in France, together accounting for nearly half of all mortality, according to the latest data from Santé publique France and …
-
Cemag Care Launches Haima: A Non-Hormonal Option for Heavy Menstrual Bleeding Managing heavy menstrual bleeding—clinically known as menorrhagia—often involves a choice between hormonal treatments or prescription-only medications. The introduction of …
-
Metformin and Longevity in Women: A Potential Link to Exceptional Lifespans Metformin, a widely prescribed medication for type 2 diabetes, may be associated with increased longevity in women, potentially extending …
-
Alamy The National Institute of Health and Medical Research (Inserm) published an article on February 4 on its media “Canal Détox” to refute preconceived ideas about peptides. (Illustrative photo) IN …
-
A World First: Gene therapy offers Hope for Hunter Syndrome Table of Contents A World First: Gene therapy offers Hope for Hunter Syndrome Edit cells Pioneering Gene Therapy offers Hope …